✦ LIBER ✦

Central nervous system malignancies in HIV negative ‘high risk patients’

✍ Scribed by M.G. Glaser; M.D. Leslie; C.P. Lowdell

Book ID: 108473029
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 114 KB
Volume: 6
Category: Article
ISSN: 1433-2981
DOI: 10.1016/s0936-6555(05)80374-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiepileptic therapy in patients with c

Antiepileptic therapy in patients with central nervous system malignancies

✍ Glen H. J. Stevens 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 127 KB

The management of thromboembolic disease

The management of thromboembolic disease in patients with central nervous system malignancies

✍ Mary Ann Knovich; Glenn J. Lesser 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 226 KB

Absence of simian virus 40 DNA sequences

Absence of simian virus 40 DNA sequences in primary central nervous system lymphoma in HIV-negative patients

✍ Manuel Montesinos-Rongen; Razvan Besleaga; Susanne Heinsohn; Reiner Siebert; Har 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 144 KB

Central nervous system metastases in pat

Central nervous system metastases in patients with high-risk breast carcinoma after multimodality treatment

✍ Ana M. Gonzalez-Angulo; Massimo Cristofanilli; Eric A. Strom; Aman U. Buzdar; Sh 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 1 views

Phase II evaluation of echinomycin (NSC-

Phase II evaluation of echinomycin (NSC-526417) in patients with central nervous system malignancies

✍ Sarah A. Taylor; John Crowley; Jennette Townsend; F. Stephen Vogel; Harmon Eyre; 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 298 KB

High incidence of thromboembolism in pat

High incidence of thromboembolism in patients with central nervous system lymphoma

✍ Neta Goldschmidt; Eduard Linetsky; Edna Shalom; David Varon; Tali Siegal 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

## Abstract ## BACKGROUND Venous thromboembolism (VTE) is a frequent complication in patients with cancer throughout the course of the disease. Patients with brain tumors are at particularly high risk for VTE, and several risk factors were found in patients with malignant glioma. To the authors' k